Next Article in Journal
Association between the Use of Antibiotics and the Development of Acute Renal Injury in Patients Hospitalized for COVID-19 in a Hospital in the Peruvian Amazon
Previous Article in Journal
Comparing the Efficacy and Safety Profile of Triple Fixed-Dose Combinations in COPD: A Meta-Analysis and IBiS Score
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
JCM
Volume 11
Issue 15
10.3390/jcm11154492
jcm-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Correction to J. Clin. Med. 2022, 11(8), 2196.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Ramírez-Morros et al. Sex Differences in Cardiovascular Prevention in Type 2: Diabetes in a Real-World Practice Database. J. Clin. Med. 2022, 11, 2196

by
Anna Ramírez-Morros
1,2,
Josep Franch-Nadal
3,4,
Jordi Real
3,4,
Mònica Gratacòs
3 and
Didac Mauricio
3,4,5,6,*
1
DAP-Cat Group, Unitat de Suport a la Recerca de la Catalunya Central, Institut Universitari d’Investigació en Atenció Primària Jordi Gol (IDIAP Jordi Gol), 08272 Sant Fruitós de Bages, Spain
2
Gerència Territorial de la Catalunya Central, Institut Català de la Salut, 08272 Sant Fruitós de Bages, Spain
3
DAP-Cat Group, Unitat de Suport a la Recerca de Barcelona, Institut Universitari d’Investigació en Atenció Primària Jordi Gol (IDIAP Jordi Gol), 08007 Barcelona, Spain
4
Center for Biomedical Research on Diabetes and Associated Metabolic Diseases (CIBERDEM), Instituto de Salud Carlos III, 08907 Barcelona, Spain
5
Department of Endocrinology and Nutrition, Hospital de la Santa Creu i Sant Pau and Sant Pau Biomedical Research Institute (IIB Sant Pau), 08041 Barcelona, Spain
6
Department of Medicine, University of Vic and Central University of Catalonia, 08500 Vic, Spain
*
Author to whom correspondence should be addressed.
J. Clin. Med. 2022, 11(15), 4492; https://doi.org/10.3390/jcm11154492
Submission received: 20 June 2022 / Accepted: 27 July 2022 / Published: 2 August 2022
Browse Figure
Versions Notes

Error in Figure

In the original publication [1], there was a mistake in Figure 2. This presents smoothing line charts with changes in LDL-c, total cholesterol, and statin treatment across age in subjects on primary prevention (A) and secondary prevention (B) by gender (LDL-c, low-density lipoprotein cholesterol) as published. The mistake was that primary prevention (A) and secondary prevention (B) erroneously show the same chart. The corrected Figure 2 is as follows: Smoothing line charts with changes in LDL-c, total cholesterol, and statin treatment across age in subjects on primary prevention (A) and secondary prevention (B) by gender (LDL-c, low-density lipoprotein cholesterol). This is shown below.
The authors apologize for any inconvenience caused and state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

Reference

  1. Ramírez-Morros, A.; Franch-Nadal, J.; Real, J.; Gratacòs, M.; Mauricio, D. Sex Differences in Cardiovascular Prevention in Type 2: Diabetes in a Real-World Practice Database. J. Clin. Med. 2022, 11, 2196. [Google Scholar] [CrossRef]
Jcm 11 04492 g002 550
Figure 2. Smoothing line charts with changes in LDL-c, total cholesterol, and statin treatment across age in subjects on primary prevention (A) and secondary prevention (B) by gender (LDL-c, low-density lipoprotein cholesterol).
Figure 2. Smoothing line charts with changes in LDL-c, total cholesterol, and statin treatment across age in subjects on primary prevention (A) and secondary prevention (B) by gender (LDL-c, low-density lipoprotein cholesterol).
Jcm 11 04492 g002
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Ramírez-Morros, A.; Franch-Nadal, J.; Real, J.; Gratacòs, M.; Mauricio, D. Correction: Ramírez-Morros et al. Sex Differences in Cardiovascular Prevention in Type 2: Diabetes in a Real-World Practice Database. J. Clin. Med. 2022, 11, 2196. J. Clin. Med. 2022, 11, 4492. https://doi.org/10.3390/jcm11154492

AMA Style

Ramírez-Morros A, Franch-Nadal J, Real J, Gratacòs M, Mauricio D. Correction: Ramírez-Morros et al. Sex Differences in Cardiovascular Prevention in Type 2: Diabetes in a Real-World Practice Database. J. Clin. Med. 2022, 11, 2196. Journal of Clinical Medicine. 2022; 11(15):4492. https://doi.org/10.3390/jcm11154492

Chicago/Turabian Style

Ramírez-Morros, Anna, Josep Franch-Nadal, Jordi Real, Mònica Gratacòs, and Didac Mauricio. 2022. "Correction: Ramírez-Morros et al. Sex Differences in Cardiovascular Prevention in Type 2: Diabetes in a Real-World Practice Database. J. Clin. Med. 2022, 11, 2196" Journal of Clinical Medicine 11, no. 15: 4492. https://doi.org/10.3390/jcm11154492

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop